-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
February 01, 2020 - Communication of Weight Classification for Children Who Are Overweight or Obese
1
Communication of Weight Classification for Children
Who Are Overweight or Obese
Section 1. Basic Measure Information
1.A. Measure Name
Communication of Weight Classification for Children Who Are Overweight or Obese
1.B. Measu…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-240-bmi-parent-full-report.pdf
February 01, 2020 - CHIPRA Measure 240: Parent Report of Discussion of Weight Concerns for Child
1
Parent Report of Discussion of Weight Concerns for
Child
Section 1. Basic Measure Information
1.A. Measure Name
Parent Report of Discussion of Weight Concerns for Child
1.B. Measure Number
0240
1.C. Measure Description
Ple…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - MEDLINE Searches
Comparative Effectiveness of
Medications To Reduce Risk of
Primary Breast Cancer in Women
Appendixes
Appendix A.
Searches
A1-1
Appendix A-1. Search Strategies
MEDLINE Searches
Ovid MEDLINE(R) <1950 to January Week 3 2009>
KEY QUESTIONS 2, 3, 4…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cultural-competence_research-protocol.pdf
July 09, 2014 - Published online: July 9, 2014
6
o Improved medical health outcomes, such as reduction in obesity, kidney … disease, heart disease, breast cancer, sickle cell disease
D.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - CHIPRA 194: Overuse of Imaging for the Evaluation of Children With Primary Headache Report
1
Overuse of Imaging for the Evaluation of Children with
Primary Headache
Section 1. Basic Measure Information
1.A. Measure Name
Overuse of Imaging for the Evaluation of Children with Primary Headache
1.B. Measure Numbe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - Efficacy and safety of
canagliflozin in subjects with type 2
diabetes and chronic kidney disease. … Yale,
201345 Canagliflozin Placebo RCT
269 subjects with
type 2 diabetes and
stage 3 chronic
kidney … disease 26 weeks
Change in
HbA1c
Canagliflozin 100 and 300 mg reduced HbA1c from baseline compared
-
effectivehealthcare.ahrq.gov/health-topics/diabetes-type-1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - Disposition of Comments Report for Technical Brief 14
Technical Brief Disposition of Comments Report
Research Review Title: Models of Cancer Survivorship Care
Draft review available for public comment from August 9, 2013 to September 5, 2013.
Research Review Citation: Viswanathan M, Halpern M, Sw…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - Rapid Evidence Product
April 2021
Treatments and Technologies
Supporting Appropriate Opioid Tapers
Purpose
The purpose of this topic development brief is to explore and scope the evidence on
treatments and technologies supporting appropriate opioid tapers in people with pain, in order to
help determin…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - Rapid Evidence Product
April 2021
Treatments and Technologies
Supporting Appropriate Opioid Tapers
Purpose
The purpose of this topic development brief is to explore and scope the evidence on
treatments and technologies supporting appropriate opioid tapers in people with pain, in order to
help determin…
-
integrationacademy.ahrq.gov/products/topic-briefs/polysubstance-use
February 01, 2025 - An official website of the Department of Health & Human Services
Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
The Academy
Integrating Behavioral Health & Primary Care
Expand Navi…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Table 5.A.1. Evidence Table
…
-
effectivehealthcare.ahrq.gov/health-topics/diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - Urinary tract infection: one
lingering effect of childhood kidney diseases--review
of the literature
-
effectivehealthcare.ahrq.gov/health-topics/heart-surgery
-
effectivehealthcare.ahrq.gov/health-topics/hiatal-hernia
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - Title
Appendix D. Evidence Table
Table D-1. Evidence Table
Table D-1. Evidence table for new trials included in surveillance reports for noninvasive nonpharmacological treatment for chronic pain report
Author, Year
Country
Number of Centers and Setting Inclusion/Exclusion Criteria Number …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - In
addition, it would reduce the risks of cancer and
chronic kidney disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - In
addition, it would reduce the risks of cancer and
chronic kidney disease.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/asymptomatic-bacteriuria-in-adults-screening
September 24, 2019 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Asymptomatic Bacteriuria in Adults: Screening
September 24, 2019
Recommendations made by the USPSTF are independent of the U.S. government. They should not be …